1991
DOI: 10.1016/0022-2828(91)90086-2
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
25
1

Year Published

1995
1995
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 57 publications
(27 citation statements)
references
References 10 publications
1
25
1
Order By: Relevance
“…Morphine has been shown to act on the heart via both Î-and ‰-ORs [6], which are the ORs present in the heart [32,34]. These two types of receptors have been shown to mediate cardioprotection of ischemic preconditioning [35].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Morphine has been shown to act on the heart via both Î-and ‰-ORs [6], which are the ORs present in the heart [32,34]. These two types of receptors have been shown to mediate cardioprotection of ischemic preconditioning [35].…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that both Î- [32,34] and ‰-ORs [34] exist in the heart. It has been demonstrated that cardioprotection of ischemic preconditioning was abolished by blockade of Î-or ‰-, but not Ì-ORs [35], indicating that only Î-and ‰-ORs mediate cardioprotection of ischemic preconditioning.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Receptor binding studies show that there are ‰- [2,17,43] and Î- [2,17,41,43], but not Ì-OR [17] binding sites in the heart. In a subsequent study [16], it was found that Ì-receptor binding sites are only present in the left atrium of the rat.…”
Section: Cardiac Opioid Peptides and Receptorsmentioning
confidence: 99%
“…It should be noted that although 5-receptor binding sites were shown to be present in the heart, only k-receptor binding was reported to be present in the heaft by all groups. Further study with a displacement method demon strated that the binding of [3H]-U69593, a selective k-agonist, was effectively displaced by selective kr agonists, U69593 and U50488H, but only weakly by a selective k2-agonist, Met5-enkephalin-Arg6-Phe7 [4], In addition, there was no binding site for the [3H]-etorphin, which binds to a k2, but not kisite [4]. The results suggest that k| binding sites are predominant in the heart.…”
Section: Introductionmentioning
confidence: 99%